Home » AMEX » AMEX TRADED STOCKS » ADCT () AMEX Stocks : ADCT () on Investors NewsDesk ADC Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ ADC Therapeutics First Quarter 2024 Earnings: In Line With Expectations Insider Sale: CEO Ameet Mallik Sells 29,731 Shares of ADC Therapeutics SA (ADCT) ADC Therapeutics to Participate in 2024 RBC Capital Markets Global Healthcare Conference ADC Therapeutics SA (NYSE:ADCT) First-Quarter Results: Here's What Analysts Are Forecasting For This Year ADC Therapeutics SA (NYSE:ADCT) Q1 2024 Earnings Call Transcript ADC Therapeutics Announces $105 Million Underwritten Offering of Common Shares and Pre-Funded Warrants ADC Therapeutics SA (ADCT) Reports Q1 Loss, Misses Revenue Estimates ADC Therapeutics SA's Cancer Drug Candidate Shows High Response Rate in Phase 2 Trial ADC Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates ADC Therapeutics Announces Initial Data from Investigator-Initiated Phase 2 Clinical Trial of ZYNLONTA® in Patients with Relapsed/Refractory Marginal Zone Lymphoma ADC Therapeutics Makes Grants to New Employees Under Inducement Plan ADC Therapeutics to Host First Quarter 2024 Financial Results and Pipeline Update Conference Call on May 6, 2024 ADC Therapeutics Announces Updates on LOTIS-7 Clinical Trial Evaluating ZYNLONTA® in Combination with Glofitamab or Mosunetuzumab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma ADC Therapeutics to Host a Virtual Research Investor Event on Tuesday, April 9, 2024 US$10.00 - That's What Analysts Think ADC Therapeutics SA (NYSE:ADCT) Is Worth After These Results ADC Therapeutics SA (NYSE:ADCT) Q4 2023 Earnings Call Transcript Q4 2023 ADC Therapeutics SA Earnings Call ADC Therapeutics SA (ADCT) Reports Mixed 2023 Financial Results Amid Strategic Reset ADC Therapeutics SA (ADCT) Reports Q4 Loss, Tops Revenue Estimates Yahoo! Finance: ADCT News